The role of microRNAs in osteoclasts and osteoporosis
- PMID: 25692234
 - PMCID: PMC4615571
 - DOI: 10.1080/15476286.2014.996462
 
The role of microRNAs in osteoclasts and osteoporosis
Abstract
Osteoclasts are the exclusive cells of bone resorption. Abnormally activating osteoclasts can lead to low bone mineral density, which will cause osteopenia, osteoporosis, and other bone disorders. To date, the mechanism of how osteoclast precursors differentiate into mature osteoclasts remains elusive. MicroRNAs (miRNAs) are novel regulatory factors that play an important role in numerous cellular processes, including cell differentiation and apoptosis, by post-transcriptional regulation of genes. Recently, a number of studies have revealed that miRNAs participate in bone homeostasis, including osteoclastic bone resorption, which sheds light on the mechanisms underlying osteoclast differentiation. In this review, we highlight the miRNAs involved in regulating osteoclast differentiation and bone resorption, and their roles in osteoporosis.
Keywords: 3’ untranslated region; 3’-UTR; ALP, alkaline phosphatase; BMMs, bone marrow macrophages; CBL, Casitas B-lineage lymphoma proto-oncogene; CXCL11, chemokine (C-X-C motif) ligand 11; CXCR3, chemokine (C-X-C motif) receptor 3; Calcr, calcitonin receptor; FasL, Fas ligand; Fzd3, frizzled 3; GM-CSF, Granulocyte macrophage colony-stimulating factor; ITGA5, integrin α5; M-RIP, myosin phosphatase-Rho interacting protein; MAFB, V-maf musculoaponeurotic fibrosarcoma oncogene homolog B; MiRNA, microRNA; MicroRNA; OVX, ovariectomy; PAG1, phosphoprotein associated with glycosphingolipid microdomains; PDCD4, programmed cell death 4; PIO, particle-induced osteolysis; RDX, radixin; SLC39A1, solute carrier family (zinc transporter) member 1; TOB2, transducer of ERBB2; TRAF6, TNF receptor-associated factor 6; TRAP, tartrate-resistant acid phosphatase; osteoclast; osteoporosis; sICAM1, soluble intracellular adhesion molecule.
Figures
              
              
              
              
                
                
                References
- 
    
- Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289:1504-8; PMID:10968780 - PubMed
 
 - 
    
- Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003; 423:337-42; PMID:12748652; http://dx.doi.org/10.1038/nature01658 - DOI - PubMed
 
 - 
    
- Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 2007; 40:251-64; PMID:17098490; http://dx.doi.org/10.1016/j.bone.2006.09.023 - DOI - PubMed
 
 - 
    
- Leibbrandt A, Penninger JM. RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y AcadSci 2008; 1143:123-50; PMID:19076348; http://dx.doi.org/10.1196/annals.1443.016 - DOI - PubMed
 
 - 
    
- Negishi-Koga T, Takayanagi H. Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Revi 2009; 231:241-56; PMID:19754901; http://dx.doi.org/10.1111/j.1600-065X.2009.00821.x - DOI - PubMed
 
 
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous